133 related articles for article (PubMed ID: 10450922)
1. A novel podophyllotoxin-derived compound GL331 is more potent than its congener VP-16 in killing refractory cancer cells.
Huang TS; Lee CC; Chao Y; Shu CH; Chen LT; Chen LL; Chen MH; Yuan CC; Whang-Peng J
Pharm Res; 1999 Jul; 16(7):997-1002. PubMed ID: 10450922
[TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation of GL331's cancer cell killing and apoptosis-inducing activity in combination with other chemotherapeutic agents.
Huang TS; Shu CH; Lee CC; Chen LT; Whang-Peng J
Apoptosis; 2000 Feb; 5(1):79-85. PubMed ID: 11227495
[TBL] [Abstract][Full Text] [Related]
3. Protein tyrosine phosphatase activities are involved in apoptotic cancer cell death induced by GL331, a new homolog of etoposide.
Huang TS; Shu CH; Shih YL; Huang HC; Su YC; Chao Y; Yang WK; Whang-Peng J
Cancer Lett; 1996 Dec; 110(1-2):77-85. PubMed ID: 9018084
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of GL331 in combination with paclitaxel: GL331's interference with paclitaxel-induced cell cycle perturbation and apoptosis.
Huang TS; Shu CH; Chao Y; Chen LT
Anticancer Drugs; 2001 Mar; 12(3):259-66. PubMed ID: 11290873
[TBL] [Abstract][Full Text] [Related]
5. A novel topoisomerase II poison GL331 preferentially induces DNA cleavage at (C/G)T sites and can cause telomere DNA damage.
Lee CC; Huang TS
Pharm Res; 2001 Jun; 18(6):846-51. PubMed ID: 11474790
[TBL] [Abstract][Full Text] [Related]
6. GL331 induces down-regulation of cyclin D1 expression via enhanced proteolysis and repressed transcription.
Lin S; Huang HC; Chen LL; Lee CC; Huang TS
Mol Pharmacol; 2001 Oct; 60(4):768-75. PubMed ID: 11562439
[TBL] [Abstract][Full Text] [Related]
7. GL331 inhibits HIF-1alpha expression in a lung cancer model.
Chang H; Shyu KG; Lee CC; Tsai SC; Wang BW; Hsien Lee Y; Lin S
Biochem Biophys Res Commun; 2003 Feb; 302(1):95-100. PubMed ID: 12593853
[TBL] [Abstract][Full Text] [Related]
8. Activation of CDC 25 phosphatase and CDC 2 kinase involved in GL331-induced apoptosis.
Huang TS; Shu CH; Yang WK; Whang-Peng J
Cancer Res; 1997 Jul; 57(14):2974-8. PubMed ID: 9230211
[TBL] [Abstract][Full Text] [Related]
9. Induction of apoptosis and cell cycle arrest in glioma cells by GL331 (a topoisomerase II inhibitor).
Chen Y; Su YH; Wang CH; Wu JM; Chen JC; Tseng SH
Anticancer Res; 2005; 25(6B):4203-8. PubMed ID: 16309217
[TBL] [Abstract][Full Text] [Related]
10. GL331, a topoisomerase II inhibitor, induces radiosensitization of human glioma cells.
Chen Y; Lin TY; Chen JC; Yang HZ; Tseng SH
Anticancer Res; 2006; 26(3A):2149-56. PubMed ID: 16827158
[TBL] [Abstract][Full Text] [Related]
11. L1EPO, a novel podophyllotoxin derivative overcomes P-glycoprotein-mediated multidrug resistance in K562/A02 cell line.
Chen H; Wang J; Zhang J; Wang Y; Cao B; Bai S; Yu PF; Bi W; Xie W
Biol Pharm Bull; 2009 Apr; 32(4):609-13. PubMed ID: 19336892
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of a novel podophyllotoxin derivative (TOP-53) against lung cancer and lung metastatic cancer.
Utsugi T; Shibata J; Sugimoto Y; Aoyagi K; Wierzba K; Kobunai T; Terada T; Oh-hara T; Tsuruo T; Yamada Y
Cancer Res; 1996 Jun; 56(12):2809-14. PubMed ID: 8665518
[TBL] [Abstract][Full Text] [Related]
13. Differential cytotoxicity of 19 anticancer agents in wild type and etoposide resistant small cell lung cancer cell lines.
Jensen PB; Christensen IJ; Sehested M; Hansen HH; Vindeløv L
Br J Cancer; 1993 Feb; 67(2):311-20. PubMed ID: 8094293
[TBL] [Abstract][Full Text] [Related]
14. Hypophosphorylation of topoisomerase IIalpha in etoposide (VP-16)-resistant human carcinoma cell lines associated with carboxy-terminal truncation.
Matsumoto Y; Takano H; Kunishio K; Nagao S; Fojo T
Jpn J Cancer Res; 2001 Jul; 92(7):799-805. PubMed ID: 11473732
[TBL] [Abstract][Full Text] [Related]
15. A novel podophyllotoxin derivative (YB-1EPN) induces apoptosis and down-regulates express of P-glycoprotein in multidrug resistance cell line KBV200.
Chen H; Bi W; Cao B; Yang Z; Chen S; Shang H; Yu P; Yang J
Eur J Pharmacol; 2010 Feb; 627(1-3):69-74. PubMed ID: 19879873
[TBL] [Abstract][Full Text] [Related]
16. Shortening of microsatellite deoxy(CA) repeats involved in GL331-induced down-regulation of matrix metalloproteinase-9 gene expression.
Huang TS; Lee CC; Chang AC; Lin S; Chao CC; Jou YS; Chu YW; Wu CW; Whang-Peng J
Biochem Biophys Res Commun; 2003 Jan; 300(4):901-7. PubMed ID: 12559958
[TBL] [Abstract][Full Text] [Related]
17. Novel 4 beta-anilino-podophyllotoxin derivatives: design synthesis and biological evaluation as potent DNA-topoisomerase II poisons and anti-MDR agents.
Hu C; Xu D; Du W; Qian S; Wang L; Lou J; He Q; Yang B; Hu Y
Mol Biosyst; 2010 Feb; 6(2):410-20. PubMed ID: 20094661
[TBL] [Abstract][Full Text] [Related]
18. A new quinoline derivative MS-209 reverses multidrug resistance and inhibits multiorgan metastases by P-glycoprotein-expressing human small cell lung cancer cells.
Nokihara H; Yano S; Nishioka Y; Hanibuchi M; Higasida T; Tsuruo T; Sone S
Jpn J Cancer Res; 2001 Jul; 92(7):785-92. PubMed ID: 11473730
[TBL] [Abstract][Full Text] [Related]
19. Phase II and pharmacokinetic study of GL331 in previously treated Chinese gastric cancer patients.
Liu JM; Chen LT; Chao Y; Li AF; Wu CW; Liu TS; Shiah HS; Chang JY; Chen JD; Wu HW; Lin WC; Lan C; Whang-Peng J
Cancer Chemother Pharmacol; 2002 May; 49(5):425-8. PubMed ID: 11976838
[TBL] [Abstract][Full Text] [Related]
20. Role of the vacuolar H+-ATPase in daunorubicin distribution in etoposide-resistant MCF7 cells overexpressing the multidrug-resistance associated protein.
Benderra Z; Morjani H; Trussardi A; Manfait M
Int J Oncol; 1998 Mar; 12(3):711-5. PubMed ID: 9472114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
